What is Teatis?
Teatis is a pioneering low-sugar brand offering superfood powders and mixes formulated with 100% real food sugar blockers. Developed by a team of medical professionals and nutrition specialists, Teatis products undergo rigorous testing to ensure suitability for diabetic-friendly diets and comprehensive disease management. The company was established by serial entrepreneur Hiroshi Takatoh, motivated by a personal loss to cancer to enhance nutritional accessibility for individuals with limited time or culinary skills. Teatis' distinctive powders are not only flavorful and energizing but also versatile, suitable for preparation as teas, lattes, or additions to smoothies, providing a convenient path to improved health.
How much funding has Teatis raised?
Teatis has raised a total of $700K across 1 funding round:
Angel/Seed
$700K
Angel/Seed (2021): $700K with participation from Ryo Ishizuka and Genesia Ventures
Key Investors in Teatis
Genesia Ventures
Genesia Ventures is a venture capital firm specializing in seed and early-stage investments in innovative digital startups across Asia, aiming to accelerate growth through digitization and foster sustainable industries.
Ryo Ishizuka
An individual investor participating in the seed funding round for Teatis, likely contributing strategic guidance and capital to early-stage ventures.
What's next for Teatis?
With its recent major strategic investment, Teatis is poised for significant expansion. The company's focus on diabetic-friendly and disease-management nutrition aligns with a rapidly growing consumer demand for health-focused, convenient food solutions. This capital will likely fuel product development, market penetration, and potentially broader distribution channels, solidifying Teatis' position in the competitive health food sector. The strategic nature of this financing suggests a focus on scaling operations and enhancing market reach to meet the increasing demand for effective, easy-to-use nutritional products.
See full Teatis company page
